The read at a glance
Computed from the FY2026 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 4.16 — safe zoneOK
Where the revenue comes from
Fiscal 2026, as FUKUDA DENSHI CO., LTD. reports it. History and quarterly detail are in the app.
- Medical treatment equipment¥63.7B
- Consumables and other products¥39.8B
- Physiological diagnostic equipment¥26.9B
- Patient monitoring equipment¥9.3B
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about FUKUDA DENSHI CO., LTD., every answer cited to the official filings🔒
- The Intelligence Brief — added when FUKUDA DENSHI CO., LTD.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.